Alpha Teknova, Inc. (TKNO) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -42.6%, revenue growth 13.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $40.52M |
| Revenue (TTM) | $0.0B |
| Net Margin | -42.6% |
| Operating Margin (TTM) | -39.0% |
| Net Debt / EBITDA | -0.9 |
| Revenue Growth (YoY) | 13.1% |
| EPS Growth (YoY) | -11.1% |
| FCF Growth (YoY) | -16.9% |
| Price / Book | 5.96 |
| Price / Sales | 9.26 |
| FCF Yield | -2.5% |
| Altman Z-Score | 5.00 (safe) |
| Piotroski F-Score | 5/9 |
| Piotroski checks passed | 5 of 9 |
| Industry P/E (Pharmaceutical Products) | 17.1 |
| Sector P/E (Healthcare) | 21.6 |
TKNO overview · TKNO earnings · TKNO KPIs · TKNO documents · TKNO ownership · TKNO peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.